CorMedix, Inc.

300 Connell Drive

Suite 4200

Berkeley Heights, NJ 07922

908-513-9500

908-375-2272 FAX

www.cormedix.com

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product, DefenCath™, a novel antimicrobial and antifungal catheter lock solution designed to reduce catheter-related bloodstream infections in patients receiving hemodialysis through a central venous catheter. DefenCath is already marketed as a CE Marked product in Europe and other territories under the brand name “Neutrolin.”

In parallel, CorMedix is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with active programs in surgical sutures and meshes, and topical hydrogels. The company is also working with top-tier researchers to develop taurolidine-based therapies for rare pediatric cancers. For more information, visit www.cormedix.com.